TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
2 hedge funds and large institutions have $377K invested in TITAN PHARMACEUTICAL INC in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
3,042% more capital invested
Capital invested by funds: $12K → $377K (+$365K)
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$364K |
Top Sellers
TTP Hedge Fund Activity: Q3 2016 in Review
2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q3 2016, worth a combined $377K — up 3,042% from $12K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TTP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Gagnon Securities, opening a new position worth an estimated $364K.
- 2 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q3 2016, up from 1 in Q2 2016.
- Funds reported $377K of TITAN PHARMACEUTICAL INC stock for Q3 2016, up 3,042% quarter-over-quarter.
- 1 fund opened new TITAN PHARMACEUTICAL INC positions in Q3 2016 and 0 closed out, a net change of +1 holder.
- The largest TITAN PHARMACEUTICAL INC buyer in Q3 2016 was Gagnon Securities, an estimated $364K added.
Based on aggregated 13F filings for Q3 2016.